Sung H, Ferlay J, Siegel RL et al (2021) Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA A Cancer J Clinicians 71:209–249. https://doi.org/10.3322/caac.21660

Article  Google Scholar 

Villanueva A (2019) Hepatocellular carcinoma. N Engl J Med 380:1450–1462. https://doi.org/10.1056/NEJMra1713263

Article  CAS  PubMed  Google Scholar 

Llovet JM, Castet F, Heikenwalder M et al (2022) Immunotherapies for hepatocellular carcinoma. Nat Rev Clin Oncol 19:151–172. https://doi.org/10.1038/s41571-021-00573-2

Article  CAS  PubMed  Google Scholar 

Qin S, Bi F, Gu S et al (2021) Donafenib versus sorafenib in first-line treatment of unresectable or metastatic hepatocellular carcinoma: a randomized, open-label, parallel-controlled phase II-III trial. JCO 39:3002–3011. https://doi.org/10.1200/JCO.21.00163

Article  CAS  Google Scholar 

Rebouissou S, Nault JC (2020) Advances in molecular classification and precision oncology in hepatocellular carcinoma. J Hepatol 72:215–229

Article  CAS  PubMed  Google Scholar 

Alqahtani A, Khan Z, Alloghbi A, Said Ahmed TS, Ashraf M, Hammouda DM (2019) Hepatocellular carcinoma: molecular mechanisms and targeted therapies. Medicina (Kaunas) 55(9):526. https://doi.org/10.3390/medicina55090526

Forner A, Reig M, Bruix J (2018) Hepatocellular carcinoma. Lancet 391:1301–1314

Article  PubMed  Google Scholar 

Firtina Karagonlar Z, Koc D, Iscan E, Erdal E, Atabey N (2016) Elevated hepatocyte growth factor expression as an autocrine c-Met activation mechanism in acquired resistance to sorafenib in hepatocellular carcinoma cells. Cancer Sci 107:407–416

Article  CAS  PubMed  PubMed Central  Google Scholar 

Haibe Y, Kreidieh M, El Hajj H et al (2020) Resistance mechanisms to anti-angiogenic therapies in cancer. Front Oncol 10:221

Article  PubMed  PubMed Central  Google Scholar 

Kuczynski EA, Yin M, Bar-Zion A et al (2016) Co-option of liver vessels and not sprouting angiogenesis drives acquired sorafenib resistance in hepatocellular carcinoma. J Natl Cancer Inst 108(8):djw030. https://doi.org/10.1093/jnci/djw030

Duplaquet L, Kherrouche Z, Baldacci S et al (2018) The multiple paths towards MET receptor addiction in cancer. Oncogene 37:3200–3215

Article  CAS  PubMed  Google Scholar 

Xiang QF, Zhan MX, Li Y et al (2019) Activation of MET promotes resistance to sorafenib in hepatocellular carcinoma cells via the AKT/ERK1/2-EGR1 pathway. Artif Cells Nanomed Biotechnol 47:83–89

Article  CAS  PubMed  Google Scholar 

Iwatate Y, Hoshino I, Yokota H et al (2020) Radiogenomics for predicting p53 status, PD-L1 expression, and prognosis with machine learning in pancreatic cancer. Br J Cancer 123:1253–1261

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ji GW, Zhu FP, Xu Q et al (2020) Radiomic features at contrast-enhanced CT predict recurrence in early stage hepatocellular carcinoma: a multi-institutional study. Radiology 294:568–579

Article  PubMed  Google Scholar 

Bouattour M, Raymond E, Qin S et al (2018) Recent developments of c-Met as a therapeutic target in hepatocellular carcinoma. Hepatology 67:1132–1149

Article  PubMed  Google Scholar 

Decaens T, Barone C, Assenat E et al (2021) Phase 1b/2 trial of tepotinib in sorafenib pretreated advanced hepatocellular carcinoma with MET overexpression. Br J Cancer 125:190–199

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bowen SR, Yuh WTC, Hippe DS et al (2018) Tumor radiomic heterogeneity: multiparametric functional imaging to characterize variability and predict response following cervical cancer radiation therapy. J Magn Reson Imaging 47:1388–1396

Article  PubMed  Google Scholar 

Lambin P, Leijenaar RTH, Deist TM et al (2017) Radiomics: the bridge between medical imaging and personalized medicine. Nat Rev Clin Oncol 14:749–762

Article  PubMed  Google Scholar 

Choi JY, Lee JM, Sirlin CB (2014) CT and MR imaging diagnosis and staging of hepatocellular carcinoma: part II. Extracellular agents, hepatobiliary agents, and ancillary imaging features. Radiology 273:30–50

Article  PubMed  Google Scholar 

Fan T, Li S, Li K et al (2022) A potential prognostic marker for recognizing VEGF-positive hepatocellular carcinoma based on magnetic resonance radiomics signature. Front Oncol 12:857715

Article  CAS  PubMed  PubMed Central  Google Scholar 

Yuan G, Song Y, Li Q et al (2020) Development and validation of a contrast-enhanced CT-based radiomics nomogram for prediction of therapeutic efficacy of anti-PD-1 antibodies in advanced HCC patients. Front Immunol 11:613946

Article  CAS  PubMed  Google Scholar 

Packeisen J, Buerger H, Krech R, Boecker W (2002) Tissue microarrays: a new approach for quality control in immunohistochemistry. J Clin Pathol 55:613–615

Article  CAS  PubMed  PubMed Central  Google Scholar 

van Griethuysen JJM, Fedorov A, Parmar C et al (2017) Computational radiomics system to decode the radiographic phenotype. Cancer Res 77:e104–e107

Article  PubMed  PubMed Central  Google Scholar 

Aerts HJ, Velazquez ER, Leijenaar RT et al (2014) Decoding tumour phenotype by noninvasive imaging using a quantitative radiomics approach. Nat Commun 5:4006

Article  CAS  PubMed  Google Scholar 

Sun R, Limkin EJ, Vakalopoulou M et al (2018) A radiomics approach to assess tumour-infiltrating CD8 cells and response to anti-PD-1 or anti-PD-L1 immunotherapy: an imaging biomarker, retrospective multicohort study. Lancet Oncol 19:1180–1191

Article  CAS  PubMed  Google Scholar 

Zwanenburg A, Vallieres M, Abdalah MA et al (2020) The image biomarker standardization initiative: standardized quantitative radiomics for high-throughput image-based phenotyping. Radiology 295:328–338

Article  PubMed  Google Scholar 

Tibshirani R (1997) The lasso method for variable selection in the Cox model. Stat Med 16:385–395

Article  CAS  PubMed  Google Scholar 

Gu D, Xie Y, Wei J et al (2020) MRI-based radiomics signature: a potential biomarker for identifying glypican 3-positive hepatocellular carcinoma. J Magn Reson Imaging 52:1679–1687

Article  PubMed  Google Scholar 

Vickers AJ, Elkin EB (2006) Decision curve analysis: a novel method for evaluating prediction models. Med Decis Making 26:565–574

Article  PubMed  PubMed Central  Google Scholar 

Segal E, Sirlin CB, Ooi C et al (2007) Decoding global gene expression programs in liver cancer by noninvasive imaging. Nat Biotechnol 25:675–680

Article  CAS  PubMed  Google Scholar 

Gillies RJ, Kinahan PE, Hricak H (2016) Radiomics: images are more than pictures, they are data. Radiology 278:563–577

Article  PubMed  Google Scholar 

Ng F, Kozarski R, Ganeshan B, Goh V (2013) Assessment of tumor heterogeneity by CT texture analysis: can the largest cross-sectional area be used as an alternative to whole tumor analysis? Eur J Radiol 82:342–348

Article  PubMed  Google Scholar 

Amini M, Nazari M, Shiri I et al (2021) Multi-level multi-modality (PET and CT) fusion radiomics: prognostic modeling for non-small cell lung carcinoma. Phys Med Biol 66(20). https://doi.org/10.1088/1361-6560/ac287d

Ozkan E, West A, Dedelow JA et al (2015) CT gray-level texture analysis as a quantitative imaging biomarker of epidermal growth factor receptor mutation status in adenocarcinoma of the lung. AJR Am J Roentgenol 205:1016–1025

Article  PubMed  Google Scholar 

Global Burden of Disease Liver Cancer C, Akinyemiju T, Abera S et al (2017) The burden of primary liver cancer and underlying etiologies from 1990 to 2015 at the global, regional, and national level: results from the Global Burden of Disease Study 2015. JAMA Oncol 3:1683–1691

Article  Google Scholar 

Kazemi-Shirazi L, Endler G, Winkler S, Schickbauer T, Wagner O, Marsik C (2007) Gamma glutamyltransferase and long-term survival: is it just the liver? Clin Chem 53:940–946

Article  CAS  PubMed  Google Scholar 

Llovet JM, Pena CE, Lathia CD et al (2012) Plasma biomarkers as predictors of outcome in patients with advanced hepatocellular carcinoma. Clin Cancer Res 18:2290–2300

Article  CAS  PubMed  Google Scholar 

Hassan S, Ferrario C, Mamo A, Basik M (2008) Tissue microarrays: emerging standard for biomarker validation. Curr Opin Biotechnol 19:19–25

Article  CAS  PubMed  Google Scholar